IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc. today announced that it will introduce its Moda-flx Hemodialysis System™ at ASN Kidney Week 2023, Nov. 1-5 at the Pennsylvania Convention Center in Philadelphia. The technology will also be the subject of a poster session titled “Blood Flowrate Accuracy with Diality Hemodialysis System” [SA-P0618] to be presented from 10 a.m. to noon on Saturday, Nov. 4 in the exhibit hall.
Moda-flx is a patient-inspired hemodialysis system designed to empower healthcare professionals to choose what is best for patients, as well as their clinical practice. The Diality system, which is currently not approved for sale in any region, is designed to allow healthcare professionals to choose:
- The right hemodialysis prescription in any care setting
- The water/dialysate-generation option based on what works best for them
- An interface that is easy to learn and use for specialists and non-nephrology clinicians
“Moda-flx is designed to deliver on Diality’s mission to improve lives impacted by kidney disease by reducing the burden of care for all kidney care stakeholders,” said Osman Khawar, M.D., chief executive officer for Diality. “We believe it will represent a new paradigm in the treatment of kidney disease, and we’re excited to introduce it to the kidney care community at Kidney Week.”
To view and learn more about the system, please visit Diality at ASN Kidney Week booth #2011.
About Diality
Headquartered in Irvine, Calif., Diality is a medical technology company developing a user-friendly, mobile, and connected hemodialysis system with a category-leading prescription range. The Diality system is designed to offer kidney care providers maximum flexibility as the market continues to evolve toward delivery of dialysis in a broader range of healthcare settings. Diality’s hemodialysis system is currently not approved for sale in any region. To learn more, please visit www.diality.com or find us on LinkedIn.
